SPPI - Spectrum Pharmaceuticals GAAP EPS of -$0.17 misses by $0.02
- Spectrum Pharmaceuticals press release ( NASDAQ: SPPI ): Q2 GAAP EPS of -$0.17 misses by $0.02 .
- The company’s cash, cash equivalents and marketable securities balance was approximately $68M at June 30, 2022, which provides for a cash runway into 2023.
For further details see:
Spectrum Pharmaceuticals GAAP EPS of -$0.17 misses by $0.02